Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (578)

41

Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial)

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Milinkovic, A. | Benn, P. | Arenas-Pinto, A. | +9

42

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients : 48 week results from a randomized trial (ATLAS-M)

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Di Giambenedetto, S. | Fabbiani, M. | Quiros Roldan, E. | +19

43

Cyclosporine A in addition to standard ART during primary HIV-1 infection : pilot randomized clinical trial

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Nicolás, D. | Ambrosioni, J. | Sued, O. | +15

44

Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV-Infected Subjects With Aging Biomarkers

enthalten in: CPT: pharmacometrics & systems pharmacology | 2017

von Dumond, J. | Chen, J. | Cottrell, M. | +10

45

Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen : a substudy of the randomised, open-label, non-inferiority SECOND-LINE study

enthalten in: The lancet. HIV | 2017

von Boyd, M. | Amin, J. | Mallon, P. | +14

CommentIn: Lancet HIV. 2017 Jun;4(6):e240. - PMID 28576610

46

Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection

enthalten in: Therapeutic drug monitoring | 2016

von Badri, P. | Parikh, A. | Coakley, E. | +4

47

Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children : Long-term Follow-up of the IMPAACT P1060 Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016

von Barlow-Mosha, L. | Angelidou, K. | Lindsey, J. | +17

48

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA) : a randomised, open-label, non-inferiority trial

enthalten in: The lancet. HIV | 2016

von Bunupuradah, T. | Kiertiburanakul, S. | Avihingsanon, A. | +21

CommentIn: Lancet HIV. 2016 Aug;3(8):e334-e335. - PMID 27470020

49

High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2016

von Kancheva Landolt, N. | Bunupuradah, T. | Kosalaraksa, P. | +7

50

Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy

enthalten in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception | 2016

von Ragazini, C. | Bahamondes, M. | Prandini, T. | +7